Oral Cancer : Pharmacology

Oral Cavity Cancer is associated with high incidence of loco-regional recurrences, which account for the majority of treatment failures post-surgery and radiotherapy. The time-course of relapse manifestation and metastasis are unpredictable. Relapsed OCC represents a major clinical challenge in part due to their aggressive and invasive behaviors. Chemotherapy remains the only option for advanced OCC whenever salvage surgery or re-irradiation is not feasible, but its efficacy is limited as a result of the drug resistance development. Alternatives to use of different permutations of standard cytotoxic drugs or combinations with modulators of drug resistance have led to incremental therapeutic benefits. The introduction of targeted agents and biologics against selective targets that drive cancer progression has opened-up optimism to achieve superior therapeutic activity and overcome drug resistance because, unlike the non-selective cytotoxic, the target can be monitored at molecular levels to identify patients who can benefit from the drug. This review discusses the multifactorial aspects of clinical drug resistance and emerging therapeutic approaches in recurrent OCC, emphasizing recent advances in targeted therapies, immunotherapy, and potential relevance of new concepts such as epithelial-mesenchymal transition and cancer stem cell hypothesis to drug resistance.

    Related Conference of Oral Cancer : Pharmacology

    February 20-21, 2019 |

    27th Annual Congress on Cancer Science and Targeted Therapies

    San Francisco, USA
    February 20-21, 2019

    International Meeting on Dermato Oncology

    Dallas, USA
    February 27-28, 2019

    17th International Conference on Cancer Research and Therapy

    Courtyard Marriott Seoul Times Square, Seoul, South Korea
    March 4-5, 2019

    24thAnnual meet on Surgical Oncology

    Paris, France
    March 07-08, 2019

    32nd Euro Congress on Cancer Science & Therapy

    Barcelona, Spain
    March 20-21, 2019

    10th Euro Breast Cancer Summit

    | Paris, France
    March 20-21, 2019

    15 thGLOBAL BIOMARKERS SUMMIT

    | Paris, France
    April 08-09, 2019

    3rd World Congress on Radiology and Oncology

    Abu Dhabi, UAE
    April 29-30, 2019

    33rd Global Experts Meeting on Cancer Science & Therapy

    Courtyard Marriott Seoul Times Square, Seoul, South Korea
    May 06-07, 2019

    International Conference on Frontiers in Lung Cancer

    | Radisson Hotel Narita | Tokyo, Japan
    May 6-7, 2019

    3rd Global Summit on Oncology & Cancer

    | Radisson Hotel Narita | Tokyo, Japan
    May 09-10, 2019

    15th World Congress on Blood Cancer

    Amsterdam, Netherlands
    May 13-14, 2019

    16th Asia Pacific
    Oncologists Annual Meeting

    Holiday Inn Singapore Atrium, Singapore
    July 15-16, 2019

    23rd Global Annual Oncologists Meeting

    Yokohama, Japan
    July 19-20, 2019

    Women Oncology & Nursing Care

    Atlanta, USA
    September 13-14, 2019

    31st Experts Meet On Cancer Therapy

    | Holiday Inn Singapore Atrium | Singapore
    October 10-11, 2019 |

    37th World Cancer Conference

    Dublin, Ireland
    October 14-15, 2019

    4th World Conference on Breast and Cervical Cancer

    Helsinki, Finland
    October 21-22, 2019

    4th World Congress on Frontiers in Cancer Research and Therapy

    Melbourne, Australia
    November 11-12 2019

    3rd Cancer Diagnostics & Treatment Conference

    Frankfurt, Germany

    Oral Cancer : Pharmacology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in